Experts predict that making doctors and hospitals give more details will help employers.

According to the report, employer spending on GLP-1 drugs doubled in a single year, rising from $11 to $24 per member per month. GLP-1s now account for 10.5% of all prescription drug claims, up from 6.9% in 2023.

This increase reflects the convergence of several powerful forces reshaping the health care landscape, according to a PWC report.

"Retirement is meant to be enjoyed, but many find it difficult to give themselves permission to spend the savings they've worked so hard to build," said Terri Fiedler, the company's president of retirement services.